Brocacef Nl:hub Brocacef Healthcar Pharmaceutical Import Profile — Netherlands (DGFT 2022–2026)

Name: Brocacef Nl:hub Brocacef Healthcar Pharmaceutical Import Records from India — 5 Products, $487.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Brocacef Nl:hub Brocacef Healthcar — Pharmaceutical Importer Profile (2026) | 5 Products, $487.6K Trade | TransData Nexus

Brocacef Nl:hub Brocacef Healthcar

Pharmaceutical Importer · Netherlands · Advanced Oncology Focus · $487.6K Total Trade · DGFT Verified

Brocacef Nl:hub Brocacef Healthcar is a pharmaceutical importer based in Netherlands with a total trade value of $487.6K across 5 products in 2 therapeutic categories. Based on 31 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Brocacef Nl:hub Brocacef Healthcar sources from 2 verified Indian suppliers, with Intas Pharmaceuticals Limited accounting for 98.9% of imports.

Brocacef Nl:hub Brocacef Healthcar — Import Portfolio & Supplier Network

Brocacef Nl:hub Brocacef Healthcar import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Brocacef Nl:hub Brocacef Healthcar?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Intas Pharmaceuticals Limited	$7.6M	425	98.9%
Reliance Life Sciences Private Limited	$81.6K	4	1.1%

Brocacef Nl:hub Brocacef Healthcar sources from 2 verified Indian suppliers across .

What Formulations Does Brocacef Nl:hub Brocacef Healthcar Import?

Formulation	Value	Ships
Pharma drugs & medi: pelgraz 6MG/0.6ML	$1.1M	24
Pharma drugs & medi:pelgraz 6MG/0.6ML	$250.0K	5
Pharma drugs & medi montelukast accord 10 MG as per	$205.7K	6
Pharma drugs & medi spironolactone 50mg10x10taccord-germany as per	$188.5K	4
Pharma drugs & medi eplerenone 50MG 10x10t aco-pp-dk/se/no as per	$186.6K	4
Pharma drugs & medi lercanidipine hcl 20MG 2x14taccord-ie as per	$150.0K	3
Pharma drugs & medi pelgraz 6MG/0.6ML 1pfsesima_n as per	$150.0K	3
Pharma drugs & medi spironolactone 25mg10x10taccord-germany as per	$136.7K	5
Pharma drugs & medi mycophe acid360mg 5x5x10taco-pp-germany as per	$100.0K	2
Pharma drugs & medi pelgraz 6MG/0.6ML 1pfsfi/seima_n as per	$100.0K	2
Pharma drugs & medi tadalafil 20MG 3x4taccord-pp-dk/no as per	$89.2K	2
Pharma drugs & medi lercanidipine hcl 20MG 10x10taco-dkseno as per	$70.9K	2
Pharm drug&med:mycophenolat mofetil accord 500 MG Each film coated tablet contains : mycophenolate mofetil PH.EUR 500MG	$64.6K	2
Pharma drugs & medi propranolol accord 40 MG as per	$59.0K	6
Pharma drugs & medi quetiapine pr 50MG 10x10taco-germany as per	$58.4K	3

Brocacef Nl:hub Brocacef Healthcar imports 309 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Propranolol	Cardiovascular	$202.2K	13	0.3%	15
2	Carmustine	Advanced Oncology	$137.0K	10	0.6%	11
3	Fludarabine	Advanced Oncology	$64.2K	2	2.2%	12
4	Vinorelbine	Advanced Oncology	$45.3K	3	1.3%	16
5	Topotecan	Advanced Oncology	$38.9K	3	1.0%	18

Brocacef Nl:hub Brocacef Healthcar imports 5 pharmaceutical products across 2 categories into Netherlands totaling $487.6K.

Brocacef Nl:hub Brocacef Healthcar — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Brocacef Nl:hub Brocacef Healthcar is a prominent pharmaceutical importer and buyer based in the Netherlands, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Operating under the Brocacef Group, the company plays a pivotal role in the Dutch pharmaceutical distribution network, serving a diverse clientele that includes pharmacies, hospitals, general practitioners, nursing homes, and private individuals. The Brocacef Group, with a history dating back to 1798, is a leading entity in the healthcare sector, offering a comprehensive range of services encompassing wholesale distribution, pharmacy operations, and healthcare logistics. (brocacef.nl)

Headquartered in Maarssen, Utrecht, the Brocacef Group is a subsidiary of the German PHOENIX Group, a significant player in the European pharmaceutical wholesale and retail market. This affiliation enhances Brocacef's capacity to deliver integrated healthcare solutions across Europe. The company's extensive experience and entrepreneurial spirit have enabled it to establish a robust presence in the pharmaceutical supply chain, ensuring the efficient delivery of medical products and services to meet the diverse needs of the Dutch healthcare system. (brocacef.nl)

2Distribution Network

Brocacef Nl:hub Brocacef Healthcar operates an extensive distribution network within the Netherlands, characterized by strategically located warehouses and advanced logistics capabilities. The company's primary warehouse is situated in Ede, Netherlands, serving as a central hub for the intake, storage, and distribution of pharmaceutical products. This facility is equipped to handle a wide range of products, including temperature-sensitive medications, ensuring compliance with stringent storage and transportation requirements. (cdn.brocacef.nl)

The distribution network is designed to provide nationwide coverage, facilitating timely and efficient delivery of products to various healthcare providers, including pharmacies, hospitals, and care institutions. Brocacef's logistics operations are optimized for sustainability, with a commitment to achieving CO₂ neutrality by 2030. This focus on sustainable practices not only enhances operational efficiency but also aligns with the growing emphasis on environmental responsibility within the healthcare sector. (brocacef.nl)

3Industry Role

Within the Netherlands' pharmaceutical supply chain, Brocacef Nl:hub Brocacef Healthcar functions primarily as a pharmaceutical importer and wholesaler. The company is responsible for sourcing finished pharmaceutical formulations from international suppliers, including those in India, and distributing these products to various healthcare providers across the country. By importing a diverse range of pharmaceutical products, Brocacef ensures a steady supply of essential medications, contributing to the overall stability and reliability of the Dutch healthcare system. (brocacef.nl)

Brocacef's role extends beyond mere distribution; it also involves the development and implementation of health and retail concepts, aiming to enhance the accessibility and quality of healthcare services. Through its BENU brand, the company operates a network of approximately 350 pharmacies, providing consumers with access to pharmaceutical care via multiple channels, including physical stores and online platforms. (brocacef.nl)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Brocacef Nl:hub Brocacef Healthcar

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Brocacef Nl:hub Brocacef Healthcar's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from a single supplier, INTAS Pharmaceuticals Limited. This supplier accounts for approximately 98.9% of the total import value, indicating a strong reliance on INTAS for the majority of the company's pharmaceutical products. The remaining 1.1% of imports are sourced from RELIANCE LIFE SCIENCES PRIVATE LIMITED, highlighting a minimal diversification in supplier relationships.

This concentrated sourcing approach may present certain risks, such as potential supply chain disruptions due to issues with the primary supplier. However, it also suggests a strategic choice by Brocacef to establish a deep and potentially more efficient partnership with INTAS Pharmaceuticals Limited. The stability and reliability of this relationship are crucial for maintaining a consistent supply of pharmaceutical products to meet the demands of the Dutch healthcare market.

2Supply Chain Resilience

The resilience of Brocacef Nl:hub Brocacef Healthcar's supply chain is closely tied to its sourcing strategy, which is heavily dependent on INTAS Pharmaceuticals Limited for the majority of its pharmaceutical imports. This reliance underscores the importance of maintaining a robust and reliable relationship with INTAS to ensure uninterrupted supply. The minimal diversification in supplier relationships may expose the company to risks associated with potential disruptions in the supply chain, such as production delays, quality control issues, or geopolitical factors affecting trade routes.

Importing Pharmaceuticals into Netherlands — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Netherlands

1Regulatory Authority & Framework

In the Netherlands, the regulatory authority overseeing the pharmaceutical sector is the Dutch Medicines Evaluation Board (CBG-MEB), which operates under the Ministry of Health, Welfare, and Sport (VWS). The CBG-MEB is responsible for evaluating and monitoring the safety, efficacy, and quality of medicines available in the Dutch market. Key legislation governing pharmaceutical imports includes the Medicines Act (Geneesmiddelenwet), which outlines the requirements for the marketing, distribution, and importation of medicinal products. Additionally, the European Union's directives and regulations, such as the EU Falsified Medicines Directive, play a crucial role in shaping the regulatory framework for pharmaceutical imports into the Netherlands.

For Indian pharmaceutical exporters, understanding and complying with these regulatory requirements is essential for ensuring the successful importation and marketing of their products in the Dutch market. This includes obtaining the necessary marketing authorizations, adhering to Good Manufacturing Practices (GMP), and ensuring that products meet the quality standards set by the CBG-MEB and other relevant authorities.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the Netherlands are stringent, necessitating that companies obtain the appropriate permits from the CBG-MEB. This includes a wholesale distribution authorization, which permits the importation and distribution of medicinal products within the country. Additionally, compliance with Good Distribution Practice (GDP) guidelines is mandatory to ensure the quality and integrity of pharmaceutical products throughout the supply chain. For Indian exporters, obtaining a GMP certificate recognized by the European Union or the World Health Organization (WHO) is crucial, as it demonstrates adherence to internationally accepted manufacturing standards. This certification is a prerequisite for the importation of pharmaceutical products into the Netherlands. (business.gov.nl)

Brocacef Nl:hub Brocacef Healthcar — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Brocacef Nl:hub Brocacef Healthcar's product strategy focuses on importing pharmaceutical formulations in the therapeutic areas of Advanced Oncology and Cardiovascular diseases. The company's import data indicates a significant emphasis on oncology products, with Advanced Oncology accounting for 58.5% of the total import value, while Cardiovascular products constitute 41.5%.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Brocacef Nl:hub Brocacef Healthcar

What products does Brocacef Nl:hub Brocacef Healthcar import from India?

Brocacef Nl:hub Brocacef Healthcar imports 5 pharmaceutical products across 2 categories. Top imports: Propranolol ($202.2K), Carmustine ($137.0K), Fludarabine ($64.2K), Vinorelbine ($45.3K), Topotecan ($38.9K).

Who supplies pharmaceuticals to Brocacef Nl:hub Brocacef Healthcar from India?

Brocacef Nl:hub Brocacef Healthcar sources from 2 verified Indian suppliers. The primary supplier is Intas Pharmaceuticals Limited (98.9% of imports, $7.6M).

What is Brocacef Nl:hub Brocacef Healthcar's total pharmaceutical import value?

Brocacef Nl:hub Brocacef Healthcar's total pharmaceutical import value from India is $487.6K, based on 31 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Brocacef Nl:hub Brocacef Healthcar focus on?

Brocacef Nl:hub Brocacef Healthcar imports across 2 categories. The largest: Advanced Oncology (58.5%), Cardiovascular (41.5%).

Get Full Brocacef Nl:hub Brocacef Healthcar Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.